← Back to Clinical Trials
Recruiting NCT06276400

NCT06276400 LPFC Organization in Emotion-Duration Difference Estimation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06276400
Status Recruiting
Phase
Sponsor University of California, Santa Barbara
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-01-29
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Emotion valenceTimeTMS Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-01-29 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To support optimal behavior in daily life, goals and responses following emotional events should ideally incorporate not only the valence and intensity of prior emotional episodes but also their temporal features, such as the relative duration of positive vs. negative attributes. However, how specific brain regions contribute to the integration of temporal and emotional information and promote goal-directed response remains unknown. The goal of this study is to examine how specific brain regions track both emotional and temporal information of dynamic emotional events to inform other related brain regions to guide goal-oriented and context-appropriate actions. The investigators will scan healthy human participants using functional MRI (fMRI) while they view emotional image sequences and track the associated emotional and temporal (duration) information, and act accordingly. The investigators will employ multivariate patterns analysis and pattern similarity analysis to identify brain regions that represent (can decode) emotion, time, and their combined signals, as well as brain regions that represent the associated action goal. In addition, to infer the causal contributions of these brain regions in forming task-relevant representations (emotion, time, and action goal), the same participants will be recruited to receive transcranial magnetic stimulation (TMS) in these regions.

Eligibility Criteria

Inclusion Criteria: * right-handed * between the ages of 18 and 45 * be a fluent English speaker * have normal to corrected-to-normal vision. Exclusion Criteria: * if they report a current or prior diagnosis of a psychiatric disorder requiring hospitalization and/or are currently using psychiatric medication; o If they report a history of or current neurological disease (i.e., stroke, concussion, epilepsy, major head trauma, complicated migraine); * If they ever had a seizure; * If they have a family history of epilepsy or seizure disorders; * If they have a history of fainting; * If they are sleep deprived (TMS only); * If they have a history of prior surgery with metal clips, implants, devices, prosthetics, cardiac or neural implants (e.g., pacemaker; neurostimulator), or cochlear implants; * If they are unable to safely and comfortably complete an MRI: have metal in the body, recent surgery, presence of surgically implanted devices not cleared for MRI, extreme claustrophobia, if they report tattoos of the head or neck region, non-removable metal piercing anywhere on the body * Women will be asked to self-report their pregnancy status and have the option to take a pregnancy test if they wish. If there is a chance a participant is pregnant, they will not be scanned. * As part of the newly adopted UCSB BIC prescreening procedure, participants will be asked about their history of hearing issues (including loss, hyperacuity, sensitivity to loud noises, history of tinnitus (ringing in ears), job with high noise exposure, and chronic migraines. Participants will be excluded if one or more hearing issues are reported.

Contact & Investigator

Central Contact

Mengsi Li, M.S.

✉ mengsi.li@ucsb.edu

📞 805-837-5206

Principal Investigator

Regina Lapate, Ph.D.

PRINCIPAL INVESTIGATOR

University of California, Santa Barbara

Frequently Asked Questions

Who can join the NCT06276400 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06276400 currently recruiting?

Yes, NCT06276400 is actively recruiting participants. Contact the research team at mengsi.li@ucsb.edu for enrollment information.

Where is the NCT06276400 trial being conducted?

This trial is being conducted at Santa Barbara, United States.

Who is sponsoring the NCT06276400 clinical trial?

NCT06276400 is sponsored by University of California, Santa Barbara. The principal investigator is Regina Lapate, Ph.D. at University of California, Santa Barbara. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology